FDA Label for Rivive
View Indications, Usage & Precautions
Rivive Product Label
The following document was submitted to the FDA by the labeler of this product Harm Reduction Therapeutics, Inc.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Active Ingredient (In Each Spray)
Naloxone hydrochloride 3 mg
Purpose
Emergency treatment of opioid overdose
Uses
• to “revive” someone during an overdose from many prescription pain medications or street drugs such as heroin• this medicine can save a life
Directions
Step 1: CHECK if you suspect an overdose
| |
Step 2: GIVE 1st dose in the nose
| |
Step 3: CALL 911
| |
Step 4: WATCH & GIVE
| |
Step 5: STAY
|
Warning
When using this product some people may experience symptoms when they wake up, such as shaking, sweating, nausea, or feeling angry. This is to be expected.
Other Information
• store at 20°C to 25°C (68°F to 77°F)• do not refrigerate• avoid excessive heat above 40°C (104°F)• do not use if sealed blister package is torn or opened
Inactive Ingredients
hydrochloric acid, purified water, sodium chloride, sodium hydroxide, trisodium citrate dihydrate
Questions?
for more information call toll-free (888)-412-7454 or go to www.RiVive.com
Package/Label Principal Display Panel
RiVive™
Naloxone HCl Nasal Spray 3 mg
Emergency Treatment
of Opioid Overdose
FOR USE IN
THE NOSE ONLY
NOZZLE
PLUNGER
EASY
TO USE
2-Single-Dose
Nasal Spray Devices
0.003 fl oz (0.1 mL) each
HARM REDUCTION
THERAPEUTICS
Distributed by Harm Reduction Therapeutics, Inc.
Bethesda, MD 20814
Label
* Please review the disclaimer below.